Antibody to the E3 glycoprotein protects mice against lethal venezuelan equine encephalitis virus infection

J Virol. 2010 Dec;84(24):12683-90. doi: 10.1128/JVI.01345-10. Epub 2010 Oct 6.

Abstract

Six monoclonal antibodies were isolated that exhibited specificity for a furin cleavage site deletion mutant (V3526) of Venezuelan equine encephalitis virus (VEEV). These antibodies comprise a single competition group and bound the E3 glycoprotein of VEEV subtype I viruses but failed to bind the E3 glycoprotein of other alphaviruses. These antibodies neutralized V3526 virus infectivity but did not neutralize the parental strain of Trinidad donkey (TrD) VEEV. However, the E3-specific antibodies did inhibit the production of virus from VEEV TrD-infected cells. In addition, passive immunization of mice demonstrated that antibody to the E3 glycoprotein provided protection against lethal VEEV TrD challenge. This is the first recognition of a protective epitope in the E3 glycoprotein. Furthermore, these results indicate that E3 plays a critical role late in the morphogenesis of progeny virus after E3 appears on the surfaces of infected cells.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Viral / administration & dosage*
  • Binding, Competitive
  • Encephalitis Virus, Venezuelan Equine / immunology*
  • Encephalomyelitis, Venezuelan Equine / immunology
  • Encephalomyelitis, Venezuelan Equine / prevention & control*
  • Encephalomyelitis, Venezuelan Equine / virology
  • Epitopes / immunology
  • Fluorescent Antibody Technique, Indirect
  • Glycoproteins / antagonists & inhibitors
  • Glycoproteins / immunology*
  • Immunization, Passive
  • Mice
  • Mice, Inbred BALB C
  • Viral Envelope Proteins / antagonists & inhibitors
  • Viral Envelope Proteins / immunology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Viral
  • Epitopes
  • Glycoproteins
  • Viral Envelope Proteins